One scientist at the FDA's Center for Tobacco Products said the center had delayed starting new applications while staff ...

DBV Technologies (DBVT) announced that in a written responses only to the company’s Type D IND meeting request, the FDA agreed with the ...

She said the FDA had already canceled some meetings with companies or reverted to providing written responses only. A lawyer specializing in FDA regulation, who spoke on condition of anonymity ...

Eva Temkin, a lawyer at Arnold & Porter who advises clients on medical device applications, said the FDA had canceled some meetings with companies or reverted to providing written responses only.